Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance imaging-guided linear accelerator.
Apparent diffusion coefficient
Cellularity
Diffusion weighted imaging
MRI-guided radiotherapy
Journal
Physics and imaging in radiation oncology
ISSN: 2405-6316
Titre abrégé: Phys Imaging Radiat Oncol
Pays: Netherlands
ID NLM: 101704276
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
24
08
2023
revised:
04
10
2023
accepted:
30
10
2023
medline:
4
12
2023
pubmed:
4
12
2023
entrez:
4
12
2023
Statut:
epublish
Résumé
Diffusion weighted imaging (DWI) allows for the interrogation of tissue cellularity, which is a surrogate for cellular proliferation. Previous attempts to incorporate DWI into the workflow of a 0.35 T MR-linac (MRL) have lacked quantitative accuracy. In this study, accuracy, repeatability, and geometric precision of apparent diffusion coefficient (ADC) maps produced using an echo planar imaging (EPI)-based DWI protocol on the MRL system is illustrated, and Accuracy and repeatability were assessed by measuring ADC values in a diffusion phantom at three timepoints and comparing to reference ADC values. System-dependent geometric distortion was quantified by measuring the distance between 93 pairs of phantom features on ADC maps acquired on a 0.35 T MRL and a 3.0 T diagnostic scanner and comparing to spatially precise CT images. Additionally, for five sarcoma patients receiving radiotherapy on the MRL, same-day Phantom ADC quantification was accurate on the 0.35 T MRL with significant discrepancies only seen at high ADC. Average geometric distortions were 0.35 (±0.02) mm and 0.85 (±0.02) mm in the central slice and 0.66 (±0.04) mm and 2.14 (±0.07) mm at 5.4 cm off-center for the MRL and diagnostic system, respectively. In the sarcoma patients, a mean pretreatment ADC of 910x10 The acquisition of accurate, repeatable, and geometrically precise ADC maps is possible at 0.35 T with an EPI approach.
Sections du résumé
Background and purpose
UNASSIGNED
Diffusion weighted imaging (DWI) allows for the interrogation of tissue cellularity, which is a surrogate for cellular proliferation. Previous attempts to incorporate DWI into the workflow of a 0.35 T MR-linac (MRL) have lacked quantitative accuracy. In this study, accuracy, repeatability, and geometric precision of apparent diffusion coefficient (ADC) maps produced using an echo planar imaging (EPI)-based DWI protocol on the MRL system is illustrated, and
Materials and methods
UNASSIGNED
Accuracy and repeatability were assessed by measuring ADC values in a diffusion phantom at three timepoints and comparing to reference ADC values. System-dependent geometric distortion was quantified by measuring the distance between 93 pairs of phantom features on ADC maps acquired on a 0.35 T MRL and a 3.0 T diagnostic scanner and comparing to spatially precise CT images. Additionally, for five sarcoma patients receiving radiotherapy on the MRL, same-day
Results
UNASSIGNED
Phantom ADC quantification was accurate on the 0.35 T MRL with significant discrepancies only seen at high ADC. Average geometric distortions were 0.35 (±0.02) mm and 0.85 (±0.02) mm in the central slice and 0.66 (±0.04) mm and 2.14 (±0.07) mm at 5.4 cm off-center for the MRL and diagnostic system, respectively. In the sarcoma patients, a mean pretreatment ADC of 910x10
Conclusions
UNASSIGNED
The acquisition of accurate, repeatable, and geometrically precise ADC maps is possible at 0.35 T with an EPI approach.
Identifiants
pubmed: 38045642
doi: 10.1016/j.phro.2023.100505
pii: S2405-6316(23)00096-9
pmc: PMC10692914
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100505Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: JW, the first and corresponding author, has nothing to declare. Amongst the coauthors, TA was an employee of ViewRay, Inc at the time this work was performed and owned ViewRay, Inc stocks at that time. EGM, JMF, and SAR have been supported by a grant/contract from ViewRay, Inc. KL and SAR have consulted for ViewRay, Inc.
Références
J Magn Reson Imaging. 2015 Mar;41(3):610-5
pubmed: 24590513
Radiol Med. 2012 Feb;117(1):96-101
pubmed: 21744251
Med Phys. 2021 Jun;48(6):3262-3372
pubmed: 33908045
Magn Reson Med. 2016 Jul;76(1):32-44
pubmed: 26208304
J Magn Reson. 2011 Sep;212(1):116-23
pubmed: 21764614
J Proteome Res. 2019 Jul 5;18(7):2826-2834
pubmed: 31120258
Magn Reson Med. 2002 Jun;47(6):1202-10
pubmed: 12111967
Radiother Oncol. 1997 Jan;42(1):1-15
pubmed: 9132820
Radiology. 1986 Nov;161(2):401-7
pubmed: 3763909
Med Phys. 2021 Apr;48(4):1540-1545
pubmed: 33580556
Cancer. 2004 Apr 1;100(7):1365-73
pubmed: 15042669
Neoplasia. 2009 Feb;11(2):102-25
pubmed: 19186405
Radiother Oncol. 2014 Oct;113(1):115-20
pubmed: 25304719
Eur J Radiol. 2021 Apr;137:109609
pubmed: 33647779
J Magn Reson Imaging. 2011 Jan;33(1):189-93
pubmed: 21182138
Clin Cancer Res. 2020 Apr 15;26(8):1829-1836
pubmed: 32054730
Cancers (Basel). 2022 Jun 20;14(12):
pubmed: 35740691
Cancers (Basel). 2020 Jun 08;12(6):
pubmed: 32521645
Clin Transl Radiat Oncol. 2019 Apr 08;18:66-67
pubmed: 31341978
Front Oncol. 2022 Nov 29;12:867792
pubmed: 36523999
Med Phys. 2017 Oct;44(10):5357-5366
pubmed: 28692129
Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):785-792
pubmed: 27788951
AJNR Am J Neuroradiol. 2017 Mar;38(3):537-545
pubmed: 28007768
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1606-1618
pubmed: 33340604
Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1304-16
pubmed: 27354136
Eur J Radiol. 2003 Mar;45(3):169-84
pubmed: 12595101
Phys Imaging Radiat Oncol. 2020 Oct 17;16:69-73
pubmed: 33458346
Sci Rep. 2016 Jul 27;6:30618
pubmed: 27461165
J Comput Assist Tomogr. 2015 Sep-Oct;39(5):760-5
pubmed: 26017920
Eur Radiol. 2003 Nov;13(11):2409-18
pubmed: 12928954
J Magn Reson Imaging. 2022 Mar;55(3):842-853
pubmed: 34535940
J Magn Reson Imaging. 2008 Nov;28(5):1195-200
pubmed: 18972359
Cancer Imaging. 2012 Sep 28;12:395-402
pubmed: 23022595
Radiology. 2016 Jan;278(1):13-32
pubmed: 26690990
Eur Radiol. 2010 Jul;20(7):1703-14
pubmed: 20179939
Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):373-85
pubmed: 23197155
Radiother Oncol. 2019 Apr;133:156-162
pubmed: 30935572
Magn Reson Imaging. 2014 May;32(4):342-9
pubmed: 24512795
Magn Reson Med. 1986 Dec;3(6):823-33
pubmed: 3821461
Eur Radiol. 2006 Aug;16(8):1651-8
pubmed: 16532356
Sci Rep. 2015 Jul 17;5:12242
pubmed: 26184509
Stat Methods Med Res. 2015 Feb;24(1):68-106
pubmed: 24919829
J Magn Reson Imaging. 1999 Jan;9(1):53-60
pubmed: 10030650
Radiother Oncol. 2021 Nov;164:155-162
pubmed: 34592363
Radiother Oncol. 2020 Dec;153:106-113
pubmed: 33017604
Cancers (Basel). 2023 Mar 30;15(7):
pubmed: 37046741
Clin Imaging. 2012 Mar-Apr;36(2):98-103
pubmed: 22370130
Semin Radiat Oncol. 2014 Jul;24(3):196-9
pubmed: 24931092
Clin Transl Radiat Oncol. 2017 Oct 10;7:13-19
pubmed: 29594224
Clin Transl Radiat Oncol. 2019 Apr 08;18:98-101
pubmed: 31341983
Cancer Radiother. 2020 Oct;24(6-7):635-644
pubmed: 32859466
Med Phys. 1996 Jun;23(6):815-50
pubmed: 8798169
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):394-403
pubmed: 26678659
Eur Radiol. 2021 Jul;31(7):4514-4527
pubmed: 33409773
Cells. 2021 Oct 01;10(10):
pubmed: 34685601
Med Phys. 2016 Mar;43(3):1369-73
pubmed: 26936721
Radiother Oncol. 2022 Sep;174:141-148
pubmed: 35902042
Br J Radiol. 2017 Mar;90(1071):20160739
pubmed: 28079398
Medicine (Baltimore). 2018 May;97(19):e0447
pubmed: 29742688
Phys Med Biol. 2009 Jun 21;54(12):N229-37
pubmed: 19451689
Magn Reson Imaging. 2022 Oct;92:1-9
pubmed: 35644448
Magn Reson Med. 2007 Jul;58(1):167-173
pubmed: 17659608
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e21-7
pubmed: 22414281
Med Phys. 2010 Apr;37(4):1714-21
pubmed: 20443492
Radiology. 1988 Aug;168(2):497-505
pubmed: 3393671
Sci Rep. 2019 Oct 1;9(1):14099
pubmed: 31576001
AJNR Am J Neuroradiol. 2022 Feb;43(2):202-206
pubmed: 35058300
Med Phys. 2021 Nov;48(11):7228-7235
pubmed: 34520081
Magn Reson Med Sci. 2021 Mar 1;20(1):60-68
pubmed: 32147641
Radiother Oncol. 2011 Jan;98(1):68-73
pubmed: 20951452
IEEE Trans Med Imaging. 2011 Feb;30(2):424-37
pubmed: 20934948
J Appl Clin Med Phys. 2021 Feb;22(2):118-125
pubmed: 33450146